{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:21:20Z","timestamp":1778656880820,"version":"3.51.4"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2017,7,27]],"date-time":"2017-07-27T00:00:00Z","timestamp":1501113600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Osteoporos Int"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1007\/s00198-017-4169-y","type":"journal-article","created":{"date-parts":[[2017,7,26]],"date-time":"2017-07-26T22:56:47Z","timestamp":1501109807000},"page":"3251-3259","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":46,"title":["Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8\u00a0years\u2019 experience in a single center"],"prefix":"10.1007","volume":"28","author":[{"given":"J. H.","family":"Koh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. P.","family":"Myong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.-W.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-K.","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.-H.","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. H.","family":"Ju","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,7,27]]},"reference":[{"issue":"6","key":"4169_CR1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell RG, Watts NB, Ebetino FH, Rogers MJ (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 19(6):733\u2013759","journal-title":"Osteoporos Int"},{"issue":"6","key":"4169_CR2","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1002\/1529-0131(199906)42:6<1246::AID-ANR22>3.0.CO;2-U","volume":"42","author":"MC Hochberg","year":"1999","unstructured":"Hochberg MC, Ross PD, Black D, Cummings SR, Genant HK, Nevitt MC, Barrett-Connor E, Musliner T, Thompson D (1999) Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. Arthritis Rheum 42(6):1246\u20131254","journal-title":"Arthritis Rheum"},{"issue":"4","key":"4169_CR3","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1210\/jcem.87.4.8415","volume":"87","author":"MC Hochberg","year":"2002","unstructured":"Hochberg MC, Greenspan S, Wasnich RD, Miller P, Thompson DE, Ross PD (2002) Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. J Clin Endocrinol Metab 87(4):1586\u20131592","journal-title":"J Clin Endocrinol Metab"},{"issue":"14","key":"4169_CR4","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.1462","volume":"302","author":"CA Brauer","year":"2009","unstructured":"Brauer CA, Coca-Perraillon M, Cutler DM, Rosen AB (2009) INcidence and mortality of hip fractures in the united states. JAMA 302(14):1573\u20131579","journal-title":"JAMA"},{"issue":"8","key":"4169_CR5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1001\/jama.2009.1231","volume":"302","author":"WD Leslie","year":"2009","unstructured":"Leslie WD, O\u2019Donnell S, Jean S et al (2009) TRends in hip fracture rates in canada. JAMA 302(8):883\u2013889","journal-title":"JAMA"},{"issue":"9","key":"4169_CR6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0278-2391(03)00720-1","volume":"61","author":"RE Marx","year":"2003","unstructured":"Marx RE (2003) Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg 61(9):1115\u20131117","journal-title":"J Oral Maxillofac Surg"},{"issue":"3","key":"4169_CR7","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1210\/jc.2004-0952","volume":"90","author":"CV Odvina","year":"2005","unstructured":"Odvina CV, Zerwekh JE, Rao DS, Maalouf N, Gottschalk FA, Pak CY (2005) Severely suppressed bone turnover: a potential complication of alendronate therapy. J Clin Endocrinol Metab 90(3):1294\u20131301","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4169_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s00198-012-2042-6","volume":"24","author":"DH Solomon","year":"2013","unstructured":"Solomon DH, Mercer E, Woo SB, Avorn J, Schneeweiss S, Treister N (2013) Defining the epidemiology of bisphosphonate-associated osteonecrosis of the jaw: prior work and current challenges. Osteoporos Int 24(1):237\u2013244","journal-title":"Osteoporos Int"},{"issue":"1","key":"4169_CR9","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1093\/rheumatology\/ket236","volume":"53","author":"E Suresh","year":"2014","unstructured":"Suresh E, Pazianas M, Abrahamsen B (2014) Safety issues with bisphosphonate therapy for osteoporosis. Rheumatology (Oxford) 53(1):19\u201331","journal-title":"Rheumatology (Oxford)"},{"key":"4169_CR10","doi-asserted-by":"publisher","unstructured":"Pedrazzoni M, Giusti A, Girasole G, Abbate B, Verzicco I, Cervellin G (2016) Atypical femoral fractures in Italy: a retrospective analysis in a large urban emergency department during a 7-year period (2007\u20132013). J Bone Miner Metab. doi:\n10.1007\/s00774-016-0790-7","DOI":"10.1007\/s00774-016-0790-7"},{"key":"4169_CR11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.bone.2016.01.002","volume":"85","author":"JC Lo","year":"2016","unstructured":"Lo JC, Hui RL, Grimsrud CD, Chandra M, Neugebauer RS, Gonzalez JR, Budayr A, Lau G, Ettinger B (2016) The association of race\/ethnicity and risk of atypical femur fracture among older women receiving oral bisphosphonate therapy. Bone 85:142\u2013147","journal-title":"Bone"},{"key":"4169_CR12","doi-asserted-by":"crossref","unstructured":"Kim SC, Kim DH, Mogun H, Eddings W, Polinski JM, Franklin JM, Solomon DH (2016) Impact of the US Food and Drug Administration\u2019s safety-related announcements on the use of bisphosphonates after hip fracture. J Bone Miner Res 31(8):1536\u20131540","DOI":"10.1002\/jbmr.2832"},{"issue":"8","key":"4169_CR13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","volume":"305","author":"LY Park-Wyllie","year":"2011","unstructured":"Park-Wyllie LY, Mamdani MM, Juurlink DN, Hawker GA, Gunraj N, Austin PC, Whelan DB, Weiler PJ, Laupacis A (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305(8):783\u2013789","journal-title":"JAMA"},{"issue":"1","key":"4169_CR14","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/art.39429","volume":"68","author":"JH Koh","year":"2016","unstructured":"Koh JH, Myong JP, Jung SM, Lee J, Kwok SK, Park SH, Ju JH (2016) Atypical femoral fracture in rheumatoid arthritis patients treated with bisphosphonates: a nested case-control study. Arthritis Rheumatol 68(1):77\u201382","journal-title":"Arthritis Rheumatol"},{"issue":"1","key":"4169_CR15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","volume":"29","author":"E Shane","year":"2014","unstructured":"Shane E, Burr D, Abrahamsen B, Adler RA, Brown TD, Cheung AM, Cosman F, Curtis JR, Dell R, Dempster DW, Ebeling PR, Einhorn TA, Genant HK, Geusens P, Klaushofer K, Lane JM, McKiernan F, McKinney R, Ng A, Nieves J, O'Keefe R, Papapoulos S, Howe TS, van der Meulen MC, Weinstein RS, Whyte MP (2014) Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res 29(1):1\u201323","journal-title":"J Bone Miner Res"},{"key":"4169_CR16","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.bone.2014.06.008","volume":"66","author":"Y Saita","year":"2014","unstructured":"Saita Y, Ishijima M, Mogami A, Kubota M, Baba T, Kaketa T, Nagao M, Sakamoto Y, Sakai K, Kato R, Nagura N, Miyagawa K, Wada T, Liu L, Obayashi O, Shitoto K, Nozawa M, Kajihara H, Gen H, Kaneko K (2014) The fracture sites of atypical femoral fractures are associated with the weight-bearing lower limb alignment. Bone 66:105\u2013110","journal-title":"Bone"},{"issue":"4","key":"4169_CR17","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0968-0160(02)00049-2","volume":"9","author":"T Koshino","year":"2002","unstructured":"Koshino T, Takeyama M, Jiang LS, Yoshida T, Saito T (2002) Underestimation of varus angulation in knees with flexion deformity. Knee 9(4):275\u2013279","journal-title":"Knee"},{"issue":"2","key":"4169_CR18","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.knee.2013.09.008","volume":"21","author":"GM Shetty","year":"2014","unstructured":"Shetty GM, Mullaji A, Bhayde S, Nha KW, Oh HK (2014) Factors contributing to inherent varus alignment of lower limb in normal Asian adults: role of tibial plateau inclination. Knee 21(2):544\u2013548","journal-title":"Knee"},{"issue":"5","key":"4169_CR19","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/j.bone.2010.12.033","volume":"48","author":"A Giusti","year":"2011","unstructured":"Giusti A, Hamdy NA, Dekkers OM, Ramautar SR, Dijkstra S, Papapoulos SE (2011) Atypical fractures and bisphosphonate therapy: a cohort study of patients with femoral fracture with radiographic adjudication of fracture site and features. Bone 48(5):966\u2013971","journal-title":"Bone"},{"issue":"18","key":"4169_CR20","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1056\/NEJMoa1010650","volume":"364","author":"J Schilcher","year":"2011","unstructured":"Schilcher J, Michaelsson K, Aspenberg P (2011) Bisphosphonate use and atypical fractures of the femoral shaft. N Engl J Med 364(18):1728\u20131737","journal-title":"N Engl J Med"},{"issue":"5","key":"4169_CR21","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1002\/jbmr.1550","volume":"27","author":"AC Feldstein","year":"2012","unstructured":"Feldstein AC, Black D, Perrin N, Rosales AG, Friess D, Boardman D, Dell R, Santora A, Chandler JM, Rix MM, Orwoll E (2012) Incidence and demography of femur fractures with and without atypical features. J Bone Miner Res 27(5):977\u2013986","journal-title":"J Bone Miner Res"},{"issue":"4","key":"4169_CR22","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","volume":"145","author":"CA O'Brien","year":"2004","unstructured":"O'Brien CA, Jia D, Plotkin LI, Bellido T, Powers CC, Stewart SA, Manolagas SC, Weinstein RS (2004) Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength. Endocrinology 145(4):1835\u20131841","journal-title":"Endocrinology"},{"issue":"4","key":"4169_CR23","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.tem.2013.12.006","volume":"25","author":"H Henneicke","year":"2014","unstructured":"Henneicke H, Gasparini SJ, Brennan-Speranza TC, Zhou H, Seibel MJ (2014) Glucocorticoids and bone: local effects and systemic implications. Trends Endocrinol Metab 25(4):197\u2013211","journal-title":"Trends Endocrinol Metab"},{"issue":"12","key":"4169_CR24","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","volume":"147","author":"D Jia","year":"2006","unstructured":"Jia D, O'Brien CA, Stewart SA, Manolagas SC, Weinstein RS (2006) Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density. Endocrinology 147(12):5592\u20135599","journal-title":"Endocrinology"},{"issue":"1","key":"4169_CR25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","volume":"365","author":"RS Weinstein","year":"2011","unstructured":"Weinstein RS (2011) Clinical practice. Glucocorticoid-induced bone disease. N Engl J Med 365(1):62\u201370","journal-title":"N Engl J Med"},{"issue":"11","key":"4169_CR26","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","volume":"62","author":"JM Grossman","year":"2010","unstructured":"Grossman JM, Gordon R, Ranganath VK, Deal C, Caplan L, Chen W, Curtis JR, Furst DE, McMahon M, Patkar NM, Volkmann E, Saag KG (2010) American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Care Res (Hoboken) 62(11):1515\u20131526","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"5","key":"4169_CR27","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","volume":"339","author":"KG Saag","year":"1998","unstructured":"Saag KG, Emkey R, Schnitzer TJ, Brown JP, Hawkins F, Goemaere S, Thamsborg G, Liberman UA, Delmas PD, Malice MP, Czachur M, Daifotis AG (1998) Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group. N Engl J Med 339(5):292\u2013299","journal-title":"N Engl J Med"},{"issue":"20","key":"4169_CR28","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","volume":"357","author":"KG Saag","year":"2007","unstructured":"Saag KG, Shane E, Boonen S, Marin F, Donley DW, Taylor KA, Dalsky GP, Marcus R (2007) Teriparatide or alendronate in glucocorticoid-induced osteoporosis. N Engl J Med 357(20):2028\u20132039","journal-title":"N Engl J Med"},{"issue":"2","key":"4169_CR29","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1002\/art.30135","volume":"63","author":"SL Teitelbaum","year":"2011","unstructured":"Teitelbaum SL, Seton MP, Saag KG (2011) Should bisphosphonates be used for long-term treatment of glucocorticoid-induced osteoporosis? Arthritis Rheum 63(2):325\u2013328","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4169_CR30","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2010.08.011","volume":"49","author":"LI Plotkin","year":"2011","unstructured":"Plotkin LI, Bivi N, Bellido T (2011) A bisphosphonate that does not affect osteoclasts prevents osteoblast and osteocyte apoptosis and the loss of bone strength induced by glucocorticoids in mice. Bone 49(1):122\u2013127","journal-title":"Bone"},{"key":"4169_CR31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.bone.2014.04.012","volume":"64","author":"K Iwata","year":"2014","unstructured":"Iwata K, Mashiba T, Hitora T, Yamagami Y, Yamamoto T (2014) A large amount of microdamages in the cortical bone around fracture site in a patient of atypical femoral fracture after long-term bisphosphonate therapy. Bone 64:183\u2013186","journal-title":"Bone"},{"issue":"5","key":"4169_CR32","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S8756-3282(01)00414-8","volume":"28","author":"T Mashiba","year":"2001","unstructured":"Mashiba T, Turner CH, Hirano T, Forwood MR, Johnston CC, Burr DB (2001) Effects of suppressed bone turnover by bisphosphonates on microdamage accumulation and biomechanical properties in clinically relevant skeletal sites in beagles. Bone 28(5):524\u2013531","journal-title":"Bone"},{"issue":"10","key":"4169_CR33","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJMc1403799","volume":"371","author":"J Schilcher","year":"2014","unstructured":"Schilcher J, Koeppen V, Aspenberg P, Micha\u00eblsson K (2014) Risk of atypical femoral fracture during and after bisphosphonate use. N Engl J Med 371(10):974\u2013976","journal-title":"N Engl J Med"},{"issue":"1","key":"4169_CR34","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","volume":"31","author":"RA Adler","year":"2016","unstructured":"Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ, Favus MJ, Greenspan SL, McKinney R Jr, Pignolo RJ, Sellmeyer DE (2016) Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research. J Bone Miner Res 31(1):16\u201335","journal-title":"J Bone Miner Res"},{"issue":"4","key":"4169_CR35","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/art.10861","volume":"48","author":"R Emkey","year":"2003","unstructured":"Emkey R, Delmas PD, Goemaere S, Liberman UA, Poubelle PE, Daifotis AG, Verbruggen N, Lombardi A, Czachur M (2003) Changes in bone mineral density following discontinuation or continuation of alendronate therapy in glucocorticoid-treated patients: a retrospective, observational study. Arthritis Rheum 48(4):1102\u20131108","journal-title":"Arthritis Rheum"},{"issue":"1","key":"4169_CR36","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00198-005-2032-z","volume":"17","author":"JP Devogelaer","year":"2006","unstructured":"Devogelaer JP, Goemaere S, Boonen S, Body JJ, Kaufman JM, Reginster JY, Rozenberg S, Boutsen Y (2006) Evidence-based guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis: a consensus document of the Belgian Bone Club. Osteoporos Int 17(1):8\u201319","journal-title":"Osteoporos Int"},{"issue":"5","key":"4169_CR37","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1359\/jbmr.2003.18.5.919","volume":"18","author":"PN Sambrook","year":"2003","unstructured":"Sambrook PN, Kotowicz M, Nash P, Styles CB, Naganathan V, Henderson-Briffa KN, Eisman JA, Nicholson GC (2003) Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium. J Bone Miner Res 18(5):919\u2013924","journal-title":"J Bone Miner Res"},{"key":"4169_CR38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2014.02.006","volume":"63","author":"DP Taormina","year":"2014","unstructured":"Taormina DP, Marcano AI, Karia R, Egol KA, Tejwani NC (2014) Symptomatic atypical femoral fractures are related to underlying hip geometry. Bone 63:1\u20136","journal-title":"Bone"},{"issue":"2","key":"4169_CR39","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1002\/1529-0131(200002)43:2<250::AID-ANR3>3.0.CO;2-P","volume":"43","author":"EM Gravallese","year":"2000","unstructured":"Gravallese EM, Manning C, Tsay A, Naito A, Pan C, Amento E, Goldring SR (2000) Synovial tissue in rheumatoid arthritis is a source of osteoclast differentiation factor. Arthritis Rheumatism 43(2):250\u2013258","journal-title":"Arthritis Rheumatism"},{"issue":"7","key":"4169_CR40","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.2011-3256","volume":"97","author":"N Napoli","year":"2012","unstructured":"Napoli N, Jin J, Peters K, Wustrack R, Burch S, Chau A, Cauley J, Ensrud K, Kelly M, Black DM (2012) Are women with thicker cortices in the femoral shaft at higher risk of subtrochanteric\/diaphyseal fractures? The study of osteoporotic fractures. J Clin Endocrinol Metab 97(7):2414\u20132422","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"4169_CR41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00296-015-3323-0","volume":"36","author":"D Kim","year":"2016","unstructured":"Kim D, Sung YK, Cho SK, Han M, Kim YS (2016) Factors associated with atypical femoral fracture. Rheumatol Int 36(1):65\u201371","journal-title":"Rheumatol Int"},{"issue":"4","key":"4169_CR42","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1002\/jbmr.2107","volume":"29","author":"MB Zanchetta","year":"2014","unstructured":"Zanchetta MB, Diehl M, Buttazzoni M, Galich A, Silveira F, Bogado CE, Zanchetta JR (2014) Assessment of bone microarchitecture in postmenopausal women on long-term bisphosphonate therapy with atypical fractures of the femur. J Bone Miner Res 29(4):999\u20131004","journal-title":"J Bone Miner Res"}],"container-title":["Osteoporosis International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00198-017-4169-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00198-017-4169-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,10,10]],"date-time":"2017-10-10T12:34:31Z","timestamp":1507638871000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00198-017-4169-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,27]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["4169"],"URL":"https:\/\/doi.org\/10.1007\/s00198-017-4169-y","relation":{},"ISSN":["0937-941X","1433-2965"],"issn-type":[{"value":"0937-941X","type":"print"},{"value":"1433-2965","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,7,27]]}}}